Llwytho...
Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies
Neurotoxicity is an important and common complication of chimeric antigen receptor-T cell therapies. Acute neurologic signs and/or symptoms occur in a significant proportion of patients treated with CD19-directed chimeric antigen receptor-T cells for B-cell malignancies. Clinical manifestations incl...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | CNS Drugs |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7295115/ https://ncbi.nlm.nih.gov/pubmed/30387077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-018-0582-9 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|